Cutaneous Leishmaniasis Completed Phase 4 Trials for Meglumine antimoniate (DB13732)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00317980Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous LeishmaniasisTreatment